Systemic and Local Therapeutic Approaches Aim to Improve Overall Response in Cutaneous Melanoma
Source: Cancer Therapy Advisor, May 2021
Therapeutic combinations of immune checkpoint blockade with targeted, oncolytic, or antiangiogenic approaches are promising for patients with cutaneous melanoma, according to a study published in Cancers.1
Researchers sought to summarize the current therapies and emerging agents and regimens for the treatment of cutaneous melanoma.
